Puremhc
Austin, US · 1 known investors
Pure MHC is a drug discovery and development company using platform technology focused on HLA Class I and Class II target identification and validation, and provides contract research services in mass spectrometry, proteomics, peptidomics, epitope screening, and soluble HLA protein production. It develops immunotherapeutics and supports investigators working on cancer, infectious, and autoimmune diseases.
BiotechHealthtechLongevity